However, these observations suggest that inhibition of KRAS as an anti‐tumor strategy could be well tolerated even if such strategies may target the normal KRAS proteins since they appear to be dispensable for a large time window of adult homeostasis, possibly owed to compensatory roles exerted by HRAS and NRAS. This evidence concerns the gene KRAS and neoplasm.